Patients with HNF4A mutations often show reduced glucose-stimulated insulin secretion and hypoinsulinemia-induced hyperglycemia, but without evidence of beta-cell autoimmunity [63], suggesting a specific dysfunction in beta-cell regulation. The gene discussed is INS; the disease is Hyperglycemia.